ArticleMolecular biology reports2025
Association of miR-17-92 rs9588884 gene polymorphism with cognitive impairment in depression.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDepression with cognitive impairment impairs the social and learning abilities of adolescents, causing great trouble in their lives and families.
aimTo investigate the effect of miR-17-92 rs9588884 gene polymorphism on adolescents with depression with cognitive impairment.
methods155 adolescents with depression without cognitive impairment and 165 adolescents with depression with cognitive impairment were included in this study. The distribution of the miR-17-92 rs9588884 genotype was detected by the TaqMan probe method. miR-17-92 expression in serum was detected by RT-qPCR. Correlation between miR-17-92 expression and HAMD Score, MoCA Score, and MMSE Score was analyzed by Pearson correlation coefficient. Logistic regression was used to analyzed clinical factors and the risk factors in adolescents with depression with cognitive impairment.
resultsThe distribution of the miR-17-92 rs9588884 CC genotype and C gene frequency is relatively high, and the CC genotype is the pathogenic genotype for adolescents with depression and cognitive impairment. Patients with the CC genotype had higher levels of depression and more severe cognitive impairment. The expression of miR-17-92 in adolescents with depression with cognitive impairment was lower than those of adolescents with depression without cognitive impairment. miR-17-92 expression was lower in CC genotype than CG + GG genotype in adolescents with depression with cognitive impairment. The HAMD Score, MoCA Score, MMSE Score, and miR-17-92 rs9588884 CC genotype were risk factors for depressive cognitive impairment.
conclusionThe miR-17-92 rs9588884 CC genotype is pathogenic, and miR-17-92 expression was reduced in adolescents with depression with cognitive impairment.
Indexed as
Identifiers
40982055What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.